Status:
NOT_YET_RECRUITING
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Lead Sponsor:
Bardia Anvar
Collaborating Sponsors:
Carbon Life Sciences
Conditions:
Chronic Wounds
Venous Leg Ulcers (VLUs)
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Chronic wounds constitute a significant global health burden, affecting millions of individuals and contributing to increased morbidity, diminished quality of life, and rising healthcare costs. These ...
Eligibility Criteria
Inclusion
- Facilities and centers with the capacity to follow strict treatment and care guidelines for patients.
- Adults aged 18 years or older.
- Presence of a chronic wound (defined as a wound that has not shown significant improvement in 4 weeks) of any of the following etiologies: Diabetic foot ulcers, Venous leg ulcers, Arterial ulcers, Pressure ulcers, Burns, Trauma, Surgical
- Wound size greater than 1 cm²
- Ability to provide informed consent
Exclusion
- Presence of active osteomyelitis
- Untreated malignancy in the wound area
- Known allergy to components of ATPs
- Pregnant or breastfeeding women
- Patients receiving immunosuppressive therapy
- Patients with a life expectancy of less than 12 weeks
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07223892
Start Date
January 1 2026
End Date
March 1 2028
Last Update
November 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.